|
GCA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.412400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.559900E-02 |
| Normal-vs-Stage2 |
9.848600E-01 |
| Normal-vs-Stage3 |
3.164600E-01 |
| Normal-vs-Stage4 |
4.556200E-01 |
| Stage1-vs-Stage2 |
1.299820E-01 |
| Stage1-vs-Stage3 |
5.641800E-01 |
| Stage1-vs-Stage4 |
5.373600E-02 |
| Stage2-vs-Stage3 |
4.552600E-01 |
| Stage2-vs-Stage4 |
5.780400E-01 |
| Stage3-vs-Stage4 |
2.191000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.866550E-01 |
| Normal-vs-AfricanAmerican |
8.412000E-01 |
| Normal-vs-Asian |
7.925800E-01 |
| Caucasian-vs-AfricanAmerican |
2.616200E-01 |
| Caucasian-vs-Asian |
4.012800E-01 |
| AfricanAmerican-vs-Asian |
7.945400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.272600E-01 |
| Normal-vs-Female |
8.693400E-01 |
| Male-vs-Female |
1.465960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.250300E-02 |
| Normal-vs-Extreme_Weight |
3.990100E-02 |
| Normal-vs-Obese |
5.209000E-01 |
| Normal-vs-Extreme_Obese |
4.672600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.728600E-01 |
| Normal_Weight-vs-Obese |
1.226020E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.266600E-01 |
| Extreme_Weight-vs-Obese |
1.144160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.862800E-01 |
| Obese-vs-Extreme_Obese |
7.931800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.963600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.937400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.958200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.425400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.720200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.675820E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.872000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.728100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.974250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.789400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.076200E-01 |
| Normal-VS-Type2 PRCC |
1.014180E-04 |
| Normal-VS-KIRP CIMP |
3.013900E-04 |
| Normal-VS-Unclassified PRCC |
6.468800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.09200000048193E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.616600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.207200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.41970002420777E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
4.976100E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
9.924000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.739900E-02 |
| Normal-vs-N1 |
1.368230E-01 |
| Normal-vs-N2 |
1.529990E-01 |
| N0-vs-N1 |
8.237700E-03 |
| N0-vs-N2 |
6.917600E-01 |
| N1-vs-N2 |
1.631970E-01 |
|
|
